ArticleCurrent reviews in musculoskeletal medicine2015
The ethical challenges in rheumatology.
Article in Current reviews in musculoskeletal medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Reporting of Research Ethics in Studies Focusing on Foot Health in Patients with Rheumatoid Arthritis - A Systematic Review.Journal of empirical research on human research ethics : JERHREPooled it
- Ethics statements in Rheumatology journals: present practices and future directions.Rheumatology international · 2024Article
- Big data and data processing in rheumatology: bioethical perspectives.Clinical rheumatology · 2020Review
- Have the annual trends of total hip arthroplasty in rheumatoid arthritis patients decreased?Annals of translational medicine · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ethical dilemmas arise with regularity, indeed daily, in the practice of rheumatology. As such, the practitioner must have the sensitivity and capacity to recognize them, reflect on their implications, and formulate responses directed at their mitigation. This article presents relevant ethical considerations (old and new) arising in the contemporary practice of rheumatology. A number of considerations stand out for their relevance to the rheumatic diseases. Conspicuous among these are the high costs associated with modern antirheumatic therapy, the complex relationship between physicians and the pharmaceutical industry, as well as challenges to the provision of care to patients suffering from complex chronic diseases. In this regard, patient autonomy is discussed, as is the need to insure for the provision of the time and resources for adequate patient education. The importance of such concerns goes beyond the patients' themselves extending to the future generation of physicians who we will educate.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.